UGT1A1 variation and gallstone formation in sickle cell disease

Blood

Volumn 105, Issue 3, 2005, Pages 968-972

  Haverfield, Eden V ^a   McKenzie, Colin A ^b   Forrester, Terrence ^b   Bouzekri, Nourdine ^b   Harding, Rosalind ^b   Serjeant, Graham ^b   Walker, Thomas ^b   Peto, Tim E A ^b   Ward, Ryk ^b   Weatherall, David J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GALLSTONE FORMATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPERBILIRUBINEMIA; JAMAICA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SICKLE CELL ANEMIA;

EID: 19944433943     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-02-0521     Document Type: Article

References (28)

1. Sampietro M, Iolascon A. Molecular pathology of Crigler-Najjar type I and II and Gilbert's syndrome, Haematologica. 1999;84:150-157.
2. Crawford J, Ransil B, Narciso J, Gollan J. Hepatic microsomal bilirubin UDP-glucuronosyltransferase. J Biol Chem. 1992;267:16943-16950.
3. Bosma P, Chowdhury J, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med, 1995;333:1171-1175.
4. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet. 1996;347:578-581.
5. Aono S, Adachi Y, Uyama E, et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet. 1995;345:958-960.
6. Burchell B, Hume R. Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol. 1999;14:960-966.
7. Miners JO, McKinnon RA, Mackenzie PI. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology. 2002;181-182:453-466.
8. Galanello R, Perseu L, Melis M, et al. Hyperbilirubinaemia in heterozygous beta-thalassemia is related to co-inherited Gilbert's syndrome. Br J Haematol. 1997;99:433-436.
9. Galanello R, Cipollina M, Dessi C, Giagu N, Lai E, Cao A. Co-inherited Gilbert's syndrome: a factor determining hyperbilirubinemia in homozygous beta-thalassemia. Haematologica. 1999;84:103-105.
10. Bancroft JD, Kreamer B, Gourley GR. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr. 1998;132:656-660.
11. Galanello R, Cipollina M, Carboni G, et al. Hyperbilirubinemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert's syndrome. Eur J Pediatr. 1999;158:914-916.
12. Iolascon A, Faienza MF, Perrotta S, Meloni GF, Ruggie G, del Giudice EM. Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates. Haematologica. 1999;84:99-102.
13. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase activity: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A. 1997;94:12128-12132.
14. Heeney M, Howard T, Zimmerman S, Ware, R. UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia. J Lab Clin Med. 2003;141:279-282.
15. Galanello R, Piras S, Barella S, et al. Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia. Br J Haematol. 2001;115:926-928.
16. Premawardhena A, Fisher CA, Fathiu F, et al. Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia. Lancet. 2001;357:1945-1946.
17. del Giudice EM, Perrotta S, Nobili B, Specchia C, d'Urzo G, Iolascon A. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood. 1999;94:2259-2262.
18. Passon RG, Howard TA, Zimmerman SA, Schultz WH, Ware RE. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. J Pediatr Hematol Oncol. 2001;23:448-451.
19. Serjeant BE, Forbes M, Williams LL, Serjeant GR. Screening cord bloods for detection of sickle cell disease in Jamaica. Clin Chem. 1974;20:666-669.
20. Serjeant GR, Serjeant BE. Management of sickle cell disease; lessons from the Jamaican Cohort Study. Blood Rev. 1993;7:137-145.
21. Walker TM, Hambleton IR, Serjeant GR. Gallstones in sickle cell disease: observations from The Jamaican Cohort study. J Pediatr. 2000;136:80-85.
22. Betke K, Marti H, Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature. 1959;184:1877-1878.
23. Lathe G, Ruthven C. Factors affecting the rate of coupling of bilirubin and conjugated bilirubin in the Van Den Bergh reaction. J Clin Pathol. 1962;11:155-161.
24. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning, A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
25. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 1986;51:263-273.
26. Sokal R, Rohlf F. Biometry. 3rd ed. New York, NY: W.H. Freeman and Company; 1995.
27. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A. 1998;95:8170-8174.
28. Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, Di Rienzo A. Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics. 1999;9:591-599.